PSG_209637 - Draft Guidance on Semaglutide
FDA-2007-D-0369-2610Other
Comments
0
Awaiting comments
Deadline
61 days
Closes Sep 29, 2026
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from the source system.
- Title
- PSG_209637 - Draft Guidance on Semaglutide
- Posted
- Jul 29, 2026
- Comment period
- Jul 29, 2026 – Sep 29, 2026
Analysis
Overview
No comments yet — comment period open · 61 days left.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
No comments match.